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LAUE CRYSTALLOGRAPHY
It's show time
New crystallographic techniques make it possible to observe directly all
of the intermediates in an enzymatic reaction. Such a series of structures
can be combined to create a detailed movie of enzymatic catalysis.
The goal of any enzymologist is a complete understand-
ing of how an enzyme catalyzes a chemical reaction.
Until recently, this aspiration was satisfied by determining
both a kinetic and a chemical mechanism. The kinetic
mechanism for an enzyme is complete when the order
of events and the rates of all of those events have
been determined for one catalytic cycle. The chemical
mechanism is complete when the structures of all of the
intermediates and transition states between those inter-
mediates have been described. Figuring out these mecha-
nisms usually requires a variety of techniques, which
commonly include steady-state and pre-steady-state
kinetic analyses, inhibition studies and determining of
the effects of isotopes on the reaction.
What is generally missing from these studies is a descrip-
tion of all of the interactions formed between the enzyme
and the intermediates on the reaction pathway, including
all of the motions of the protein necessary to form these
transient bonds. The important residues in the active site
of an enzyme can often be identified - for example, by
chemical modification studies, pH profiles, site-directed
mutagenesis and sequence comparisons - but these stud-
ies fall far short of explaining how the key residues are
used during catalysis. What enzymologists would really
like to have is a series of structures at all of the important
points of the reaction. When done with true substrates,
such a molecular movie would constitute a new type of
mechanism in enzymology - the structural mechanism.
X-ray crystallography is the obvious tool to use to deter-
mine the structural mechanism of an enzyme. Unfortu-
nately (as collaborators around the world can attest),
crystallography is slow and enzymes are very fast. Even
under the best circumstances, monochromatic data coll-
ection takes hours, whereas enzymes usually take only
milliseconds to catalyze a reaction. During the long time
necessary to collect a useful X-ray diffraction data set, the
enzyme cycles through many catalytic events. Under
normal conditions, the structures determined from such
Fig. 1. (a) The kinetic mechanism of isocitrate dehydrogenase 111,1 2]. Either NADP or isocitrate (Iso) can bind to the apo enzyme (E). Once
both molecules are bound, the first of the ternary complexes (ElIso NADP) is formed. During the first chemical step, the isocitrate is con-
verted to oxalosuccinate (Oxa). The oxalosuccinate intermediate (E-Oxa-NADP) then decarboxylates, leaving a final ternary complex of
a-ketoglutarate (Kg) and NADPH (E-Kg-NADPH); the two products dissociate in a random fashion, leaving the apo enzyme ready for another
round of catalysis. (b) The chemical mechanism of isocitrate dehydrogenase. The first panel corresponds to the ternary complex E-Iso-NADP.
The enzymatic base (B) is probably Asp 283 [91. In the second step, the essential metal ion stabilizes the anion generated after oxalosucci-
nate decarboxylates. Finally, an enzymatic acid (AH) donates a proton to form ot-ketoglutarate. The identity of this acid is not yet known.
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diffraction data show an empty active site, as the apo
(unbound) enzyme has lower free energy than any of the
bound intermediates.
These problems in the construction of a structural mech-
anism can be overcome in two very different ways. By
altering the substrate and product concentrations in the
crystal lattice, it is sometimes possible to make one
enzyme-bound intermediate have a lower free energy
than all the others (see box). Some of the intermediates
that occur during the reaction catalyzed by chymotrypsin
have been trapped in this way [1,2]. The other solution is
to collect X-ray data sets on the enzymatic timescale.
Using the polychromatic Laue method of data collection
at a synchrotron X-ray source, it is now possible to
obtain complete data sets on a millisecond timescale [3].
The Laue method would seem, on the surface, to solve
most of the problems in determining a structural mecha-
nism. But although the Laue method solves one problem,
it creates another. In order for the Laue method to work,
some way must be found to initiate the reaction so that
all of the molecules in the lattice are at the same state of
the reaction simultaneously. Various ways of achieving
this requisite synchronicity have been tried. One is to
induce a rapid change in a macroscopic parameter (such
as the pH) to take the enzyme from an inactive to an
active state [4]. Photolabile substrate precursors have
been used to deliver substrate to all active sites at the
same time by irradiating the crystal with light and then
collecting Laue data sets [5]. A related triggering mecha-
nism inactivates the enzyme with a photolabile inhibitor,
and then uncages the enzyme with light [6]. All of these
techniques have the problem that the synchronization of
the reaction is lost rather quickly. The successful Laue
experiments reported so far all have trapped only the first
enzymatic intermediate in a reaction, and these inter-
mediates have all been rather long lived.
Recent experiments of Bolduc et al. [7] have combined
site-directed mutagenesis with X-ray crystallography to
provide a new method for trap intermediates that occur
far along an enzymatic reaction. Bolduc et al. studied the
reaction catalyzed by isocitrate dehydrogenase. As Figure
1 shows, there are seven intermediates in this reaction.
Structures of three of the four binary complexes (those
with NADP, isocitrate and ox-ketoglutarate) have already
been reported [8-10]. In the new work, the structures
have been determined of the ternary complex with
NADP and isocitrate, as well as of the ternary complex
with oxalosuccinate and NADPH. These five available
structures give a very clear picture of exactly how iso-
citrate dehydrogenase works. A sketch of the active site is
shown in Figure 2. When isocitrate binds in the active
site, both Arg 119 and Arg 129 move to lock the sub-
strate in place [8,9]. These side chains move by as much
as 2.1 A towards isocitrate, and are clearly responsible for
making isocitrate a sticky substrate.
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intermediate with oxalosuccinate and the intermediate
with ot-ketoglutarate. There has been some question as to
whether oxalosuccinate is a true intermediate in the
reaction. In order to settle this controversy, isocitrate and
ot-ketoglutarate were both refined against the data.
Difference maps clearly show that the intermediate in the
active site of the Laue experiment is oxalosuccinate.
Interestingly, in this intermediate, both Thr 104 and
Asn 115 have returned to their normal positions, and as a
result, the nicotinamide portion of the NADPH cofactor
is once again disordered.
Fig. 2. The active site of isocitrate dehydrogenase. Arg 119 and
Arg 129 are the clamps which hold the substrate in place. Lys 230
and Tyr 160 were the sites of the mutations used by Bolduc et al.
[71to trap some of the ternary complexes. Ser 113 is the site of
regulatory phosphorylation [81.
Although the binding site for isocitrate in isocitrate
dehydrogenase is clear from the structure of the binary
complex, the exact location of the other substrate,
NADP, is not revealed in the structure of its binary com-
plex [9]. NADP is a large molecule with two distinct
parts; the reaction chemistry occurs in the nicotinamide
ring portion of the molecule. This ring is disordered and
unobservable in the binary complex. The other part of
NADP, the adenosine 2',5'-diphosphate, makes a number
of good hydrogen-bond interactions with the protein and
is clearly observed in the binary complex.
Bolduc et al. [7] used site-directed mutagenesis to substi-
tute tyrosine residue 160 of isocitrate dehydrogenase by
phenylalanine. When they adjusted the substrate concen-
trations to high levels and collected data on this Y160F
mutant, Bolduc et al. were able to trap the ternary com-
plex between the enzyme, isocitrate and NADP. The
electron density in the active site of the mutant enzyme
reveals the missing portion of the NADP cofactor. The
nicotinamide ring was induced to assume a single confor-
mation by the motion of two side chains: Thr 104 moved
by 2.5 A to form a new hydrogen bond to the cofactor,
and Asn 115 moved by 1.0 A to position the nicotin-
amide cofactor in exactly the right orientation to accept
the hydride from isocitrate. These motions were the most
significant changes in the active site. The presence of neg-
atively charged isocitrate close to the positively charged
nicotinamide ring also helped to stabilize the ring.
This set of structures presents an almost complete view of
how isocitrate dehydrogenase works. The local motions
which are necessary for catalysis could not have been
guessed from the structure of the native enzyme alone or
even from the structures of the binary complexes. How-
ever, the structural mechanism for isocitrate dehydroge-
nase is not yet complete. The identity of the enzyme
bound acid (AH in Fig. lb) is still not clear. Presumably
this character will be introduced in the final frames of the
movie (the binary complex with NADPH and the
ternary complex of NADPH with ao-ketoglutarate). The
isocitrate dehydrogenase movie has clearly become a
good detective story, and like all good mysteries the
culprit will not be revealed until the end of the show.
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In order to observe the next intermediate on the path-
way, a second mutant, with lysine residue 230 replaced
by methionine, was used. With this K230M mutant, the
rate-determining step in the reaction occurs between the
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